Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPS-2071 in Bacterial Enteritis
NCT02473393Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Aug 2015
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 2 trial of OPS-2071 in bacterial enteritis, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Aug 2015; status: completed.
02
Drugs
OPS-2071
03
Conditions
bacterial enteritis
Beyond the preview
Go deeper on NCT02473393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02473393.